Advertisement
Advertisement

IMRX

IMRX logo

Immuneering Corporation Class A Common Stock

8.31
USD
+0.45
+5.75%
Sep 16, 16:00 UTC -4
Closed
exchange

After-Market

8.47

+0.16
+1.96%

Immuneering Corporation Class A Common Stock Profile

About

Immuneering Corporation is a biopharmaceutical company advancing a pipeline of oncology and neuroscience product candidates. The company's product candidate includes IMM-1-104. Immuneering Corporation is based in CAMBRIDGE, Mass.

Info & Links

CEO

Benjamin J. Zeskind

Headquarters

245 MAIN STREET, SECOND FLOOR
CAMBRIDGE, MA 02142, UNITED STATES

Sector

Medical

Auditor

RSM US LLP

Share holders

60

Employees

66

Immuneering Corporation Class A Common Stock Statistics

Valuation Measures

Market Capitalization2

352.31M

Enterprise Value

325.95M

Enterprise Value/EBITDA(ttm)

-5.14

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.96

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-119.22%

Return on Invested Capital(ttm)

-154.75%

Return on Assets(ttm)

-99.22%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-63.46M

Net Income Available to Common(ttm)

-62.13M

Diluted EPS(ttm)

-1.96

Share Statistics

Beta (5Y Monthly)

0.37

52-Week Change

311.49%

S&P 500 52-Week Change

17.28%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

36.32M

Dividend Yield

0.00%

Float4

27.75M

% Held by Insiders

22.90%

% Held by Institutions

67.65%

Balance Sheet

Total Cash(mrq)

26.36M

Total Cash Per Share(mrq)

0.73

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.70%

Quick Ratio(mrq)

7.48%

Book Value Per Share(mrq)

0.80

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.65

Free Cash Flow(ytd)

-23.54M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement